These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [What is new in basal cell carcinoma?]. Heppt M; von Braunmühl T; Berking C Hautarzt; 2016 Nov; 67(11):876-883. PubMed ID: 27654826 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know. Wiznia LE; Federman DG Am J Med; 2016 Jul; 129(7):655-60. PubMed ID: 27046242 [TBL] [Abstract][Full Text] [Related]
5. Management of high-risk and advanced basal cell carcinoma. Puig S; Berrocal A Clin Transl Oncol; 2015 Jul; 17(7):497-503. PubMed ID: 25643667 [TBL] [Abstract][Full Text] [Related]
6. Identifying patients at risk for recurrent or advanced BCC. Hamid O; Goldenberg G J Drugs Dermatol; 2013 Nov; 12(11):1246-52; quiz 1253-4. PubMed ID: 24196332 [TBL] [Abstract][Full Text] [Related]
7. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma. Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490 [TBL] [Abstract][Full Text] [Related]
8. Guidelines of care for the management of basal cell carcinoma. ; ; Kim JYS; Kozlow JH; Mittal B; Moyer J; Olencki T; Rodgers P J Am Acad Dermatol; 2018 Mar; 78(3):540-559. PubMed ID: 29331385 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Management of Basal Cell Carcinoma. Tanese K Curr Treat Options Oncol; 2019 Feb; 20(2):13. PubMed ID: 30741348 [TBL] [Abstract][Full Text] [Related]
11. Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus. Peris K; Licitra L; Ascierto PA; Corvò R; Simonacci M; Picciotto F; Gualdi G; Pellacani G; Santoro A Future Oncol; 2015; 11(4):703-12. PubMed ID: 25686123 [TBL] [Abstract][Full Text] [Related]
12. Update of the European guidelines for basal cell carcinoma management. Trakatelli M; Morton C; Nagore E; Ulrich C; Del Marmol V; Peris K; Basset-Seguin N; Eur J Dermatol; 2014; 24(3):312-29. PubMed ID: 24723647 [TBL] [Abstract][Full Text] [Related]
13. Hedgehog pathway inhibitor in combination with radiation therapy for basal cell carcinomas of the head and neck : First clinical experience with vismodegib for locally advanced disease. Schulze B; Meissner M; Ghanaati S; Burck I; Rödel C; Balermpas P Strahlenther Onkol; 2016 Jan; 192(1):25-31. PubMed ID: 26449347 [TBL] [Abstract][Full Text] [Related]
14. Interventions for basal cell carcinoma of the skin. Bath-Hextall FJ; Perkins W; Bong J; Williams HC Cochrane Database Syst Rev; 2007 Jan; (1):CD003412. PubMed ID: 17253489 [TBL] [Abstract][Full Text] [Related]
15. [Locally advanced basal-cell carcinoma: Combined alternative treatments beyond surgery]. Amici JM; Beylot-Barry M Ann Chir Plast Esthet; 2015 Aug; 60(4):321-5. PubMed ID: 25708732 [TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma: an evidence-based treatment update. Clark CM; Furniss M; Mackay-Wiggan JM Am J Clin Dermatol; 2014 Jul; 15(3):197-216. PubMed ID: 24733429 [TBL] [Abstract][Full Text] [Related]
17. Vismodegib in the treatment of advanced BCC. O'Kane GM; Lyons T; McDonald I; Mulligan N; Moloney FJ; Murray D; Kelly CM Ir Med J; 2014; 107(7):215-6. PubMed ID: 25226719 [TBL] [Abstract][Full Text] [Related]
18. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial. Dessinioti C; Plaka M; Stratigos AJ Future Oncol; 2014 May; 10(6):927-36. PubMed ID: 24941979 [TBL] [Abstract][Full Text] [Related]
19. [Basal cell carcinoma]. Takenouchi T Gan To Kagaku Ryoho; 2006 Oct; 33(10):1398-403. PubMed ID: 17033227 [TBL] [Abstract][Full Text] [Related]
20. Nonsurgical Treatments for Nonmelanoma Skin Cancer. Collins A; Savas J; Doerfler L Dermatol Clin; 2019 Oct; 37(4):435-441. PubMed ID: 31466584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]